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Abstract
Background: Hypoxemia may compromise cell metabolism and organ function.
Supplemental oxygen (O2) at high concentrations may prove ineffective, and issues
relating to hyperoxia, barotrauma, mechanical ventilation, and extracorporeal
oxygenation are well documented. Old reports suggest the potential safety and
efficacy of alternative routes for O2 administration, such as intravenous or intestinal.
We re-explored these routes in rat models of hypoxemia.
Methods: Hypoxemia was induced in spontaneously breathing, anesthetized rats by
breathing a hypoxic gas mix (FiO2 0.1). Pilot studies infusing pure O2 gas caused
early death, likely due to pulmonary embolism. Instead, rats (n = 6/group) were given
intravenous O2 via a continuous infusion of pre-oxygenated Hartmann’s solution
(10 ml/kg/h) for 3 h with normal Ringer’s lactate used in control animals. In separate
experiments (n = 8/group), bowel intraluminal oxygenation was assessed with pure
O2 administered through a cannula placed into the jejunal lumen at a dose of a
15 ml/kg bolus followed by a continuous infusion of 50 ml/kg/h; no treatment was
given to controls. Echocardiography, arterial blood gas analysis, mean arterial
pressure, muscle and liver tPO2, muscle microvascular perfused vessel density, and
urine output were measured.
Results: Administration of oxygenated Hartmann’s solution (PO2 of solution at end-
experiment = 87.5 ± 1.7 kPa) was safe but did not increase either systemic or tissue
oxygenation. Similarly, the administration of bowel O2 was safe but did not improve
neither systemic nor liver oxygenation.
Conclusions: In this rat model of hypoxemia, the intravenous infusion of gaseous O2
was unfeasible as it induced early mortality. Although safe, both intravenous infusion
of oxygenated Hartmann’s solution and bowel O2 administration were unable to
improve arterial or tissue oxygenation.
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Background
During hypoxemia, the low tissue oxygen (O2) supply may compromise cellular aerobic
metabolism and determine organ dysfunction. Supplemental O2 at high concentration,
with or without supported ventilation, is usually administered for hypoxemic respira-
tory failure. However, this conventional approach may prove inadequate when gas
exchange through the alveolar-capillary membrane is severely impeded, e.g., severe
acute respiratory distress syndrome [1]. In addition, adverse effects of excessive in-
spired O2 administration and mechanical ventilation are well documented, including
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hyperoxia- and ventilator-induced acute lung injury [2]. Extracorporeal membrane oxy-
genation is an alternative albeit invasive modality that is also associated with a signifi-
cant complication rate including bleeding, thrombosis, and infection [3].
A century ago, Tunnicliffe and Stebbing reported rapid and safe symptomatic relief of
cyanosis in patients following the administration of intravenous O2 gas through a
peripheral venous cannula at a rate of 600–1200 ml/h [4]. The authors did however
recommend that “irregularity of the pulse” and “dilatation of the right side of the heart”
are indications to stop the gas administration [4]. In 1888, John Harvey Kellogg at the
Battle Creek Sanitarium in Michigan showed that O2 may be rapidly absorbed through
the intestinal mucosa and encouraged the use of O2 enemata as a remedy for respira-
tory failure-induced cyanosis and reported several successfully treated cases [5]. These
routes for O2 administration warrant re-exploration as potentially easy and cheap alter-
natives to conventional O2 therapy. We therefore sought to determine the safety and
efficacy of intravenous and intestinal O2 administration in a rat model of hypoxemia.
Methods
All experiments were performed according to Home Office (UK) guidelines under the
1986 Scientific Procedures Act with local (University College London) ethics committee
approval (PPL 70/8290). Spontaneously breathing male Wistar rats (300–350 g body
weight) were anesthetized by 5 % isoflurane in room air in an induction chamber and
then placed on a heated mat to maintain rectal temperature at 37 °C throughout. Under
2 % isoflurane anesthesia, the left common carotid artery and right internal jugular vein
were cannulated. The arterial line was connected to a pressure transducer (Powerlab,
AD Instruments, Chalgrove, UK) for continuous monitoring of mean arterial pressure
(MAP). A tracheostomy was performed and connected to a T-piece to maintain
anesthesia and vary the fraction of inspired O2 (FiO2). The bladder was exposed
through a small laparotomy and cannulated using a 1.57-mm-OD tubing for drainage
and quantification of urine output. A small incision was made on the external side of
the right hind limb, and an 18-gauge guidance cannula was used to insert a tissue O2
tension (tPO2) sensor (Oxylite, Oxford Optronix, Milton Park, Oxon, UK) into the
right vastus lateralis muscle [6]. For measurement of liver tPO2, the probe was
placed into the airtight space between two of the liver lobes through a small mid-
line laparotomy [6]. To enable microcirculatory assessment, a 2-cm skin incision
was performed on the medial side of the left hind limb, and the perimysium was
carefully separated from the muscle by blunt dissection in order to minimize tissue
damage and bleeding [7].
In 16 animals (bowel O2 model), a 2-cm midline laparotomy was additionally per-
formed to allow insertion of an 18-gauge cannula into the jejunum to which it was se-
cured by a suture. The cannula was exteriorized to enable injection of O2, and the
abdomen was closed with sutures. After instrumentation, isoflurane was reduced to
1.2 % for the remainder of the experiment. Euvolemia was obtained by intravenous ad-
ministration of 4 ml/kg Hartmann’s solution followed by a continuous infusion of
10 ml/kg/h. The animals were allowed to stabilize for 60 min before baseline measure-
ments were taken. The FiO2 was then reduced to 0.1 and maintained until the end of
the experiment to induce hypoxemia. At the end of the study, the animals were sacri-
ficed without regaining consciousness.
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Model 1: intravenous O2 administration
Pilot studies were performed to construct a model of intravenous administration of gaseous
O2. The infusion of pure O2 gas at a slow rate of 2 ml/kg/h (approximately 0.67 ml/h)
resulted in death within minutes. The demise was preceded by a sharp fall in MAP and
dilatation of the right ventricle evidenced by echocardiography, suggesting acute heart
failure due to pulmonary embolism. Therefore, this technique was abandoned.
As an alternative, oxygenated Hartmann’s solution was prepared by bubbling pure O2 gas
into a bag of Hartmann’s solution until the fluid was fully saturated. An O2 tension (PO2)
of 100 kPa within the solution was confirmed by gas analysis (ABL625 blood gas analyzer,
Radiometer, Copenhagen, Denmark). The PO2 of the solution was re-assessed at end-
experiment. After 60 min of hypoxemia, animals (n = 6/group) were randomized to receive
a continuous infusion of 10 ml/kg/h of oxygenated Hartmann’s solution (IV-O2 group) or
an equal volume of normal, non-oxygenated Hartmann’s solution (control group) over the
following 3 h. Measurements were taken at baseline and at hourly intervals for 4 h.
Model 2: bowel O2 administration
After 30 min of hypoxemia, eight animals (bowel O2 group) received an injection of 15 ml/
kg of pure O2 gas into the jejunal lumen, followed by continuous administration at a rate of
50 ml/kg/h for 90 min. These volumes were determined in pilot studies as the maximum
volumes not producing any signs of intestinal over-distension or ischemia. No oxygen treat-
ment was administered to a control group (n= 8). Measurements were taken at baseline and
at 30-min intervals for 120 min. Five animals per group were monitored for a further 2 h.
Measurements
Echocardiography (Vivid 7, GE Healthcare, Bedford, UK) was performed to assess
stroke volume (SV), heart rate (HR), and respiratory rate (RR). SV was calculated from
the flow-velocity integral measured in the ascending aorta (assuming an aortic annulus
radius of 1.4 mm [6]) by pulsed-wave Doppler. Arterial and venous blood samples
(about 0.2 ml) were collected in heparinized capillary tubes for blood gas analyses
(ABL625 analyzer), which included measurements of arterial base excess (ABE) and lac-
tate. Cumulative urine output was measured at 120 min (bowel O2 model) and at the
end of the experiment. Muscle and liver tPO2 were assessed using large-area-surface
O2 sensors (0.7-mm diameter) connected to an Oxylite tissue monitoring system, as de-
scribed previously [7]. The skeletal muscle microcirculation was evaluated with side-
stream dark field videomicroscopy (Microscan, Microvision Medical, Amsterdam, NL),
which enables real-time in vivo visualization of blood flow in microvascular beds [8].
Videos from five adjacent sites were recorded with adequate contrast, focus, and stabil-
ity; an absence of pressure artifact was defined by preservation of venular perfusion.
The perfused vessel density (PVD), representing the total length of vessels with a con-
tinuous/sluggish flow divided by the total surface of the image, was calculated offline
using AVA 3.0 (Automated Vascular Analysis) software (MicroVision Medical) [9].
Statistics
Statistical analysis was performed using Graph Pad version 5 (GraphPad Software, La
Jolla, CA, USA). Normality of distribution was checked using the Kolmogorov-Smirnov
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test. Data are expressed as mean ± standard error or median [first to third quartile], as
appropriate. Statistics on parametric data were performed using repeated measures
two-way analysis of variance followed by Bonferroni’s post hoc test. Non-parametric
data were analyzed using the Friedman test with Dunn’s post hoc test for multiple com-
parisons and the Mann-Whitney U test. A p value <0.05 was used to indicate statistical
significance.
Results
Model 1: intravenous O2 administration
All animals survived until the end of the 4-h experiment. At baseline, no statistically
significant differences were observed between the two groups in any of the variables
measured. After 1 h of breathing 10 % O2, similar reductions in arterial PO2, arterial
and venous O2 saturation (SO2), and tissue PO2 in the muscle and liver were observed
in the two groups (Fig. 1). A similar decrease in MAP was observed in the two groups
(p < 0.001 versus baseline). HR and SV tended to decrease and increase, respectively.
Arterial lactate levels were significantly elevated at 60 min in both groups while ABE
tended to decrease (Fig. 1). Respiratory rate tended to be elevated in both groups dur-
ing hypoxia, leading to a significant reduction in arterial carbon dioxide tension (PCO2)
and increase in pH (Table 1).
The administration of oxygenated Hartmann’s solution (PO2 of solution at end-
experiment = 87.5 ± 1.7 kPa) did not yield any significant improvement in blood or tis-
sue oxygenation (Fig. 1). Respiratory alkalosis persisted until the end of the experiment
in both groups (Table 1).
Fig. 1 Effects of intravenous oxygenated Hartmann’s solution on oxygenation and hemodynamics in
hypoxemic rats. Breathing 0.1 FiO2, rats (n = 6/group) received an intravenous infusion of 10 ml/kg/h of
oxygenated (intravenous O2) or normal Hartmann’s solution (controls) over 3 h. Arterial O2 tension (PO2), arterial
and central venous O2 saturation (SO2), muscle and liver tissue PO2, mean arterial pressure, arterial base excess
(ABE), and lactate are expressed as mean ± standard error. Heart rate and stroke volume are expressed as
median [first to third quartile]. *p < 0.05, **p < 0.01, and ***p < 0.001 versus baseline in the intravenous O2
group; #p < 0.05, ##p < 0.01, and ###p < 0.001 versus baseline in the control group (repeated measure two-way
analysis of variance with Bonferroni’s post hoc test or Friedman test with Dunn’s post hoc test)
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A non-significant increase in microcirculatory PVD was observed at 60 min in both
groups (Table 1). No significant differences were found between the two groups
throughout the experiment, apart from a lower value at 60 min in the IV-O2 groups as
compared to controls (p = 0.011, Table 1).
Cumulative urine output at 240 min did not differ between the two groups (6.5 [5.5–18.9]
ml/kg in the IV-O2 group and 5.8 [4.9–6.4] ml/kg in controls, p = 0.238).
Model 2: bowel O2 administration
All animals survived until the end of the experiment. At baseline, no statistically signifi-
cant differences were observed between the two groups in any of the variables mea-
sured. After 30 min of breathing 10 % O2, similar changes in arterial PO2, arterial and
venous SO2, and tPO2 in the muscle and liver were observed in the two groups (Fig. 2).
MAP was significantly reduced in both groups (p < 0.001 versus baseline); HR tended
to decrease while SV tended to increase (Fig. 2). Arterial lactate levels were elevated in
both groups (p < 0.01 versus baseline) while ABE was significantly reduced only in the
bowel O2 group (p = 0.012 versus baseline) (Fig. 2). Respiratory rate increased following
hypoxemia in both groups, leading to respiratory alkalosis (Table 2).
The administration of O2 into the jejunal lumen did not produce any significant dif-
ference in any of the respiratory or hemodynamic variables measured over the course
of the experiment. No differences were found between bowel O2 and control groups at
any time points (Fig. 2). Arterial lactate levels decreased during bowel O2 administra-
tion (p = 0.22 versus baseline at 120 min) but rose again over the following 2 h once
the oxygen was discontinued (p = 0.06 versus baseline at 240 min). Arterial PCO2 and
pH remained significantly altered throughout the experiment in both groups but did
not differ between the groups (Table 2).
Microcirculatory PVD did not change significantly following hypoxemia and no dif-
ferences were found between the groups at any time points (Table 2).
Cumulative urine output was similar between the two groups at 120 min (3.4
[2.8–6.4] ml/kg in the bowel O2 group and 3.1 [2.3–6.0] ml/kg in controls, p = 0.32,
Table 1 Respiratory and microcirculatory data for model 1 (intravenous O2 administration)
Baseline 60 min 120 min 180 min 240 min
Respiratory rate (n/min)
IV-O2 65 [62–73] 71 [69–77] 75 [71–83]* 75 [71–81]* 72 [69–79]
Controls 77 [60–89] 83 [67–96] 81 [69–94] 85 [69–93] 84 [69–97]
PaCO2 (kPa)
IV-O2 4.8 ± 0.1 3.8 ± 0.1** 3.5 ± 0.1** 3.5 ± 0.1** 3.3 ± 0.1**
Controls 4.8 ± 0.1 3.5 ± 0.1** 3.4 ± 0.2** 3.2 ± 0.1** 3.1 ± 0.1**
pH
IV-O2 7.44 ± 0.01 7.52 ± 0.01** 7.53 ± 0.01** 7.53 ± 0.02** 7.53 ± 0.02**
Controls 7.47 ± 0.01 7.55 ± 0.01** 7.56 ± 0.01** 7.57 ± 0.01** 7.57 ± 0.01**
Perfused vessel density (mm/mm2)
IV-O2 17.0 ± 0.7 19.5 ± 1.0*** 18.5 ± 0.6 18.6 ± 0.4 18.5 ± 0.8
Controls 20.9 ± 0.7 24.6 ± 2.1 21.8 ± 1.0 20.8 ± 1.7 20.2 ± 0.9
*p < 0.01; **p < 0.001 versus baseline; ***p < 0.05 versus controls
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n = 8/group) and 240 min (7.0 [6.1–13.1] ml/kg in the bowel O2 group and 6.4 [5.8–12.0]
ml/kg in controls, p = 0.53, n = 5/group).
Discussion
In our rat model of hypoxemia, the infusion of pure O2 gas through a central vein was
unfeasible as it induced early death due to pulmonary embolism. The infusion of oxy-
genated Hartmann’ solution over 3 h was safe; however, it proved ineffective in increas-
ing blood or tissue oxygenation. Similarly, the administration of gaseous O2 into the
Table 2 Respiratory and microcirculatory data for model 2 (bowel O2 administration)
Baseline 30 min 120 min 240 min
Respiratory rate (n/min)
Bowel-O2 70 ± 3 81 ± 3* 81 ± 3* 82 ± 2*
Controls 69 ± 4 83 ± 4** 86 ± 5*** 81 ± 7**
PaCO2 (kPa)
Bowel-O2 4.7 ± 0.1 3.5 ± 0.1*** 3.4 ± 0.1*** 2.8 ± 0.2***
Controls 4.7 ± 0.2 3.5 ± 0.1*** 3.2 ± 0.1*** 2.8 ± 0.1***
pH
Bowel-O2 7.47 ± 0.01 7.54 ± 0.01*** 7.57 ± 0.01*** 7.53 ± 0.04***
Controls 7.47 ± 0.01 7.55 ± 0.01*** 7.56 ± 0.01*** 7.58 ± 0.01***
Perfused vessel density (mm/mm2)
Bowel-O2 20.8 [14.9–21.1] 21.2 [17.7–23.1] 21.0 [18.6–22.1] 18.5 [17.1–19.5]
Controls 19.9 [18.2–23.3] 20.0 [18.1–23.8] 18.0 [16.5–22.0] 17.9 [15.7–18.7]
*p < 0.05; **p < 0.01; ***p < 0.001 versus baseline
Fig. 2 Effects of the administration of pure O2 gas into the bowel on oxygenation and hemodynamics in
hypoxemic rats. Breathing 0.1 FiO2, rats were injected with pure O2 gas (15 ml/kg as a bolus followed by a
continuous infusion of 50 ml/kg/h for 2 h) into the jejunum (bowel O2 group, n = 8). No oxygen treatment
was given to a group of controls (n = 8). Five animals per group were monitored for a further 2 h after
infusion discontinuation. Arterial O2 tension (PO2), arterial and central venous O2 saturation (SO2), liver tissue
PO2, mean arterial pressure, heart rate, stroke volume, arterial base excess (ABE), and lactate are expressed
as mean ± standard error. Muscle tPO2 is expressed as median [first to third quartile]. *p < 0.05, **p < 0.01,
and ***p < 0.001 versus baseline in the bowel O2 group;
#p < 0.05, ##p < 0.01, and ###p < 0.001 versus
baseline in the control group (repeated measure two-way analysis of variance with Bonferroni’s post hoc
test or Friedman test with Dunn’s post hoc test)
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small bowel did not produce any improvement in oxygenation although it was not as-
sociated with any unfavorable effects.
Numerous attempts have been made in the past to oxygenate the blood by routes
other than the lung. Nysten was probably the first to inject gaseous O2 into the veins of
a living animal in 1811 [10]. The first administration to a human being dates back to
1902, when Mariani reported an improved pulse and respiration following the infusion
of 120 ml O2 over 15 min through the dorsalis pedis vein in a patient with tuberculosis,
but who died the next day [11]. Several other investigators reported encouraging results
in both animals and humans [4, 12–14]; however, these data were not confirmed by
others. It became clear that the intravenous administration of pure O2 gas could lead
to pulmonary embolism and worsened blood oxygenation [15, 16]. It was also sug-
gested that only a small amount of the gas injected could be absorbed as only a min-
imal surface of gas was in direct contact with the blood due to the coalescence of gas
bubbles [16]. Our study in hypoxemic rats supports the lack of safety of intravenous
gas infusion. We used an O2 infusion rate of 2 ml/kg/h, which would correspond to an
infusion rate of 140 ml/h for a human weighing 70 kg. There are case reports showing
that the intravenous bolus injection of 100 ml of air can cause cardiac arrest due to
fatal pulmonary embolism [17]. Other authors suggest the lethal dose for humans to be
3–5 ml/kg and that a rapid injection of 300–500 ml at a rate of 100 ml/s is fatal [18]. A
larger amount of O2 may be potentially administered in humans or large animals using
peripheral venous accesses and lower rates of infusion without hemodynamic or re-
spiratory sequelae. However, scientific evidences for this are lacking, and the questions
as to whether a sufficient volume of gas could be administered safely and absorbed to
effectively improve tissue oxygenation remain unanswered.
Despite being safe, the intravenous infusion of oxygenated Hartmann’s solution was
not able to induce any increase in blood or tissue PO2. In an experimental study in nor-
moxemic rabbits, Kim et al. reported an increase in arterial PO2 during the administra-
tion of oxygenated Ringer’s lactate through a central vein [19]. However, spontaneous
variation cannot be excluded as no control group was used in this study. The PO2 of
solution at end-experiment in our study was even higher (87.5 ± 1.7 kPa) than that re-
ported by Kim et al. (76.7 kPa); however, it must still be acknowledged that the amount
of O2 dissolved remains small. In our experiments, at 60 min hypoxemia, the average
O2 delivery (DO2) was 14.4 ± 2.6 ml/min (as calculated from the cardiac output, Hb
levels, SaO2, and PaO2) and the O2 consumption (VO2) was 5.9 ± 1.2 ml/min (as calcu-
lated from the cardiac output and the difference between the arterial and venous O2
content). According to the Henry’s law and the ideal gas law, at PO2 = 100 kPa and
temperature = 20 °C, we can estimate that the amount of O2 dissolved in the oxygen-
ated Hartmann’ solution was about 0.03127 ml O2/ml. At a fluid infusion rate of
10 ml/kg/h, a rat weighing 300 g received around 0.05 ml/min (3 ml/h) of Hartmann’
solution, containing 0.0016 ml O2/min. This represents about the 0.01 % of the total
DO2 and the 0.027 % of the total VO2, thus making an insignificant contribution to sys-
temic oxygenation.
In a guinea pig experiment, Kellogg noted that the dark blood in the portal veins as-
sumed a bright red color soon after the injection of O2 into the rectum, suggesting a
rapid absorption through the intestinal wall [5]. In a case series, Maruzok et al. re-
ported a significant increase in the PaO2/FiO2 ratio in patients with acute respiratory
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distress syndrome following the intestinal insufflation of pure O2 gas through a naso-
intestinal tube [20]. As the improvement in systemic oxygenation lasted for more than
32 h, direct intestinal absorption of O2 seemed unlikely [20]. Again, the lack of a con-
trol group prevents definitive conclusions from being drawn. In our study in hypoxemic
rats, the administration of pure O2 gas into the small bowel was unable to produce any
increase in systemic oxygenation, either rapidly (during infusion) or in the 2 h following
infusion discontinuation. The liver should have been the first organ to benefit from an
intestinal absorption of O2 into the portal veins for anatomical reasons. The observed
trend towards a reduction in arterial lactate levels during the administration of bowel
O2 might reflect an improved hepatic metabolism. However, no improvement was
seen in liver tPO2 during or after the insufflation of O2 into the bowel. By admin-
istering a 5-ml bolus of pure O2 followed by a continuous infusion of 50 ml/kg/h,
we infused a total of 27.5 ml of pure O2 for a rat weighing 300 g (5 ml + 15 ml/h
over 90 min). Even if all this O2 had been absorbed in the circulating blood over
time, this would have contributed to systemic oxygenation only by about 2 % of
the systemic DO2 (total DO2 over 90 min under FiO2 10 % = 1296 ml) and 4.2 %
of systemic VO2 (total VO2 over 90 min under FiO2 10 % = 531 ml). Our results
do not show any evidence supporting the ability of O2 to be absorbed in a detect-
able amount through the intestinal mucosa into the blood.
Other alternatives to pulmonary oxygenation have been explored over the past years.
Perfluorocarbon-based O2 carriers have been tested using several routes of administra-
tion, including intravenous [21], transintestinal [22], and transpleural [23], as well as
for liquid ventilation [24]. Nevertheless, none of these agents has been approved for
clinical use due to storage, production, and clinical evaluation complications [25].
Kheir et al. manufactured lipid-based O2-carrying microbubbles for intravenous in-
fusion that could rescue hypoxemia in asphyxiated rabbits, decreasing the incidence
of cardiac arrest and organ injury without inducing any signs of pulmonary embol-
ism [26]. The administration of phospholipid-coated O2 microbubbles into the peri-
toneal cavity was effective in increasing systemic oxygenation in animal models of
pneumothorax [27] and asphyxia [28]. The research for simple, non-invasive, and
cheap alternatives to pulmonary oxygenation is still ongoing, and further studies
are encouraged.
Some limitations of our study need to be acknowledged. Firstly, retrospective the-
oretical calculations of the amount of O2 administered in the different models
clearly show that the experimental approach applied was unsuitable to produce any
positive results. However, we designed our experiments based on previously pub-
lished reports [4, 5, 10–16, 19, 20] that represented our proof of concept. Secondly,
we constructed an artificial short-term model of hypoxemia by administering a
hypoxic gas mixture. Other experimental models of acute respiratory distress syn-
drome (e.g., by repeated pulmonary lavage [29]) could more closely reproduce the
clinical scenario. However, our method allowed a better control of the amount of
O2 absorbed in the lungs, thus limiting variability in oxygenation parameters.
Other potential routes for O2 administration were not evaluated, such as the peri-
toneal route. Mechanical ventilation of the peritoneal cavity was able to improve
oxygenation in an experimental model of acute respiratory syndrome in rabbits, in-
ducing both an increase in arterial PO2 and a decrease in arterial PCO2 [30].
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Conclusions
In hypoxemic rats, the infusion of 2 ml/kg/h of pure O2 gas into a central vein induced
early death due to pulmonary embolism. However, both the intravenous infusion of ox-
ygenated Hartmann’s solution and the administration of gaseous O2 into the small
bowel were safe but ineffective in increasing blood or tissue oxygenation. Our study
suggests the inadequacy of intravenous oxygenated fluids or intestinal insufflation of
O2 as alternative ways for O2 administration in rats.
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